The largest database of trusted experimental protocols

Cobas 8000 modular analyser series

Manufactured by Roche
Sourced in United States, Switzerland

The Cobas 8000 modular analyser series is an automated clinical chemistry and immunoassay testing system designed for high-throughput laboratory settings. It features a modular design that allows for flexible configuration to meet the specific needs of individual laboratories.

Automatically generated - may contain errors

5 protocols using cobas 8000 modular analyser series

1

Serum Bone Biomarkers in Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were obtained as part of the patients' clinical follow-up. Total serum calcium, phosphate and alkaline phosphatase were measured using colorimetric methods. Serum concentrations of 25-hydroxy vitamin D (25-OHD) and serum carboxy-terminal collagen crosslinks (CTX) were measured using automated chemiluminescence immunoassay systems (Cobas 8000 modular analyser series, Roche Diagnostics; iSYS, Immunodiagnostic Systems). The Quidel enzyme immunoassay (San Diego, CA, USA) was used to determine bone alkaline phosphatase (BAP) levels. BAP and CTX serum concentrations were converted to age- and gender-specific Z-scores based on published reference data (Koay et al., 2004 (link)). The following cut-off points were used for the serum 25-OHD levels: sufficiency above 75 nmol/L (>30 ng/mL), insufficiency between 50 and 75 nmol/L (20–30 ng/mL) and deficiency below 50 nmol/L (<20 ng/mL).
+ Open protocol
+ Expand
2

Biochemical Profiles in Neutropenia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following approved ethical guidelines from the local ethics review committee complete blood count and biochemical assessment results were obtained from the Haematology Laboratory at UHG. The data set received in 2018–2019 (discovery data set) was considered as discovery data set while the data set received in 2020–2021 (validation data set) was used to validate the results. The samples were analysed to determine changes in biochemical parameters such as serum Urea, Creatinine, Albumin, Total Protein, and serum electrolytes (Sodium, Potassium, Chloride, Phosphate, and Calcium) and haematological parameters or blood cell counts. Using the Advia 212i system, blood counts were done and biochemistry measurements were performed on serum by the Cobas 8000 modular analyser series from Roche Diagnostics. The reports of these tests were compiled for each patient and analysed for normal and abnormal absolute neutrophil counts (ANC). Each patient data obtained was further classified based on ANC into normal and moderate (0.5–1.0 × 109/L ANC) or severe (<0.5 × 109/L ANC) neutropenia. The patient data was then analysed to determine changes in biochemical parameters such as serum Urea, Creatinine, Albumin, Total Protein, and serum electrolytes (Sodium, Potassium, Chloride, Phosphate, and Calcium) which were correlated with changes in neutrophil counts.
+ Open protocol
+ Expand
3

Serum Biomarker Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected after overnight fasting. All blood samples were centrifuged, serum was fractionated and stored at −80°C until further analysis.
Serum levels of fasting glucose were analysed by the hexokinase method (COBAS, Roche Diagnostics). Insulin levels were determined with electrochemiluminescence using the immunoanalyzer COBAS e411 (Roche Diagnostics). Homeostasis model assessment-estimated insulin resistance (HOMA-IR) was calculated using the following formula (17 (link)):
C-reactive protein (CRP), TG, cholesterol and high-density lipoproteins (HDL) were routinely determined using standard laboratory assays (COBAS 8000 modular analyser series, Roche Diagnostics, Mannheim, Germany). Low-density lipoproteins (LDL) was calculated using the Friedman formula:
Non-esterified fatty acids (NEFAs) were determined with the standard enzymatic colorimetric method (P-modular; Roche Diagnostics).
+ Open protocol
+ Expand
4

Metabolic Factors Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BP and PR were obtained using an electronic sphygmomanometre (Terumo Elemano [ES-H55], Medaval, New Jersey, United States) in a comfortable sitting position after at least 15-min rest. Blood sampling was undertaken following a 12-h overnight fast. TC, HDL-c, LDL-c, TG, glucose, insulin, urine microalbumin and urine creatinine were analysed with a biochemical auto-analyser (Cobas® 8000 Modular Analyser Series, Roche Diagnostics, Indianapolis, United States). HbA1c was determined using Cobas Integra® 800 analyser, Roche Diagnostics, Indianapolis, United States. Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated as: HOMA-IR = (FPG × fasting insulin)/22.5 in molar units.
+ Open protocol
+ Expand
5

Hematological and Biochemical Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hematological parameters (hematocrit, red blood cells, platelets, total white cells, lymphocytes, monocytes, neutrophils, monocytes, eosinophils, and basophils) were counted on whole blood samples in EDTA K3 using an autoanalyser Cell-Dyn Sapphire (Abbott Laboratories, Chicago, Illinois, USA). In venous blood, measurements of serum biochemical parameters, including alanine aminotransferase (ALTL), aspartate aminotransferase (ASTL), creatinine (CREA), urea (UREA), and total bilirubin (TBIL) were performed on a Cobas 8000 Modular Analyser Series (Roche Diagnostics, Basel, Switzerland). Blood obtained by cardiac puncture was centrifuged, and serum was collected and stored at − 80 °C. Serum levels of C-reactive protein (CRP) were measured by ELISA using a rat DuoSet ELISA kit and DuoSet Ancillary Reagent Kit2 (R&D Systems, Abingdon, UK) following manufacturer's protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!